Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.
Intrinsic resistance occurs when bacterial structural components inherently prevent antibiotic efficacy. For example, Gram-negative bacteria possess an outer wall that restricts the entry of certain antibiotics. Some bacteria, such as Enterococcus faecium, alter their peptidoglycan structure to resist vancomycin, while others modify porin openings and numbers to prevent antibiotic penetration.
Another widespread mechanism involves efflux pumps, which actively expel antibiotics from bacterial cells. Escherichia coli and other pathogens utilize these pumps to remove multiple antibiotics, contributing to multidrug resistance. Additionally, some bacteria bypass drug actions by adopting alternative metabolic pathways, as seen in Leishmania spp.
Many bacteria produce enzymes that degrade or modify antibiotics. Staphylococcus aureus and Escherichia coli synthesize β-lactamases, which hydrolyze the β-lactam ring of penicillins and cephalosporins, rendering them ineffective. Some superbugs, such as methicillin-resistant Staphylococcus aureus (MRSA), evade antibiotics by modifying penicillin-binding proteins (PBPs). These alterations prevent β-lactam antibiotics from inhibiting cell wall synthesis, leading to treatment failures with conventional antibiotics.
Resistance can also develop through spontaneous mutations in chromosomal DNA, allowing bacteria to survive selective pressure from antibiotics. Additionally, horizontal gene transfer through conjugation, transformation, or transduction enables bacteria to acquire resistance genes from other strains.
Beyond resistance, some bacteria exhibit antibiotic tolerance. Mycobacterium tuberculosis, for instance, can enter a dormant state where metabolic activity is reduced, making it less susceptible to antibiotic action. Biofilm formation further enhances bacterial survival by creating a protective matrix that hinders antibiotic penetration.
Antibiotic resistance is a genetically encoded trait that enables bacteria to survive antibiotic treatments.
Some bacteria exhibit intrinsic resistance, such as cell walls of Gram-negative bacteria, naturally restricting antibiotic entry.
Enterococcus faecium alters its peptidoglycan to resist vancomycin, while some bacteria downregulate porins to limit antibiotic entry.
Efflux pumps, as found in E. coli, can expel several antibiotics, contributing to multidrug resistance.
Penicillin-resistant bacteria produce enzymes that degrade β-lactam rings, blocking cell wall disruption, though not all β-lactams are affected.
Superbugs like methicillin-resistant Staphylococcus aureus carry genetic islands that alter penicillin-binding proteins, making β-lactams and other antibiotics ineffective.
Some pathogens, like Leishmania spp., can bypass drug action using alternative metabolic pathways.
Resistance can arise from spontaneous mutations in chromosomal DNA or through horizontal gene transfer of resistance genes.
Certain bacteria, like Mycobacterium tuberculosis, can temporarily withstand antibiotics by entering dormancy or forming biofilms.
繁體中文
